Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 1, 2005, Pages 107-108

  Rashid, Mohammad H ^a   Welsh, Cynthia T ^a   Bissada, Nabil K ^b   Chaudhary, Uzair B ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chemotherapy; Doxorubicin; Ifosfamide; Interferon; Sarcomatoid renal cell carcinoma

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; INTERFERON;

ABDOMINAL SURGERY; ADRENALECTOMY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY SARCOMA; NEPHRECTOMY; POSITRON EMISSION TOMOGRAPHY; SARCOMA; SARCOMATOID RENAL CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; DOXORUBICIN; FEMALE; HUMANS; IFOSFAMIDE; INTERFERONS; KIDNEY NEOPLASMS; MIDDLE AGED; REMISSION INDUCTION;

EID: 13444268939     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000139938.76332.6e     Document Type: Article

References (4)

1. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001;25:275-284.
2. Cangiano T, Liao J, Naitoh J, et al. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol. 1999;17:523.
3. Sella A, Logothetis C, Samuels M, et al. Sarcomatoid renal cell carcinoma. A treatable entity. Cancer, 1987;60:1313-1318.
4. Escudier B, Droz J, Terrier-Lacombe M, et al. Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers. J Urol. 2002;168:959-961.